Full Text View
Tabular View
No Study Results Posted
Related Studies
Omalizumab (Xolair) and Allergy Shots For the Treatment of Seasonal Allergies
This study has been completed.
Study NCT00078195   Information provided by National Institute of Allergy and Infectious Diseases (NIAID)
First Received: February 19, 2004   Last Updated: May 13, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hay Fever
Hypersensitivity
Allergy
Rhinitis
Additional conditions recognized in this trial
Rhinitis, Allergic, Seasonal
More general conditions related to this trial
Hypersensitivity, Immediate
Immune System Diseases
Nose Diseases
Otorhinolaryngologic Diseases
Respiratory Hypersensitivity
Respiratory Tract Diseases
Respiratory Tract Infections
Interventions listed in this trial
omalizumab
More general drug interventions related to this trial
Anti-Allergic Agents
Anti-Asthmatic Agents
Pharmacologic Actions
Respiratory System Agents
Therapeutic Uses
Sponsors listed in this trial
National Institute of Allergy and Infectious Diseases (NIAID)
Immune Tolerance Network


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services